<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 29, 2019 (HealthDay News) — Abdominoplasty is safe and effective in obese patients, with no significant differences in perioperative complication rates compared with nonobese patients, according to a study published in the April issue of Plastic and Reconstructive Surgery<\/i>.<\/p>\n
Joseph Batac, M.D., from the Long Island Plastic Surgical Group in Garden City, New York, and colleagues retrospectively reviewed the charts on all patients who underwent abdominoplasty by a single surgeon from 2009 to 2016. Complication rates in 21 obese and 62 nonobese patients were compared. Follow-up time was similar (310 days versus 265 days; P = 0.468) in the two groups.<\/p>\n
The researchers found no significant differences with regard to perioperative seroma formation (14.2 versus 22.5 percent; P = 0.419), wound dehiscence (9.5 versus 11.29 percent; P = 0.822), hematoma formation (4.7 versus 1.6 percent; P = 0.438), or surgical-site infection (9.5 versus 8 percent; P = 0.835). There were no occurrences of venous thromboembolism.<\/p>\n
“Abdominoplasty, with or without concurrent liposuction, in obese patients, is a safe and effective procedure with similar perioperative complication rates as the nonobese patient population,” the authors write.<\/p>\n